Lexicon Pharmaceuticals
LXRX
#7096
Rank
โ‚น61.37 B
Marketcap
โ‚น137.92
Share price
2.11%
Change (1 day)
12.98%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น13.79

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น14.27. In 2025 the company made an earnings per share (EPS) of -โ‚น13.32 an increase over its 2024 EPS that were of -โ‚น60.88.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น13.793.54%
2025-โ‚น13.32-78.13%
2024-โ‚น60.88-20%
2023-โ‚น76.1031.15%
2022-โ‚น58.02-0%
2021-โ‚น58.0210.91%
2020-โ‚น52.32-145.08%
2019โ‚น116.05-206.09%
2018-โ‚น109.39-5.74%
2017-โ‚น116.05-10.95%
2016-โ‚น130.312640%
2015-โ‚น4.76-96.34%
2014-โ‚น129.80-2.53%
2013-โ‚น133.17-9.09%
2012-โ‚น146.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,771-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น514.60-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,986-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น555.50 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น952.15-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.90-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.34 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.15-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,786 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA